Cua Clifford L, Thiagarajan Ravi R, Taeed Roozbeh, Hoffman Timothy M, Lai Lillian, Hayes John, Laussen Peter C, Feltes Timothy F
Department of Pediatrics, Division of Pediatric Cardiology, Columbus Children's Hospital, Columbus, Ohio 43205-2696, USA.
Ann Thorac Surg. 2005 Jul;80(1):44-9. doi: 10.1016/j.athoracsur.2005.01.059.
Modification of the Norwood procedure has been reported to improve immediate postoperative mortality compared with the classic Norwood. Interstage mortality has not been shown to be improved with the modified Norwood probably because of the small number of patients from each institution. The goal of this study was to determine if meta-analysis would provide sufficient data to prove statistical difference in interstage mortality for the modified Norwood procedure.
PubMed was searched using six different terms individually for articles from January 2003 to October 2004. Manuscripts that compared the classic to modified Norwood were reviewed. Mantel-Haenszel analysis was used to evaluate the relationship between treatment method and mortality stratified across hospitals. The Breslow-Day procedure tested homogeneity of odds ratio across hospitals. Separate analyses were performed for inpatient and interstage periods.
A total of 4,545 citations was screened. Five manuscripts met the criteria. Seventy-two patients undergoing classic Norwood and 84 patients undergoing modified Norwood survived to initial hospital discharge. The Breslow-Day statistic supported homogeneity of odds ratios for survival across hospitals (chi2 = 2.09, df = 4, p = 0.72). Odds of interstage death was 11.6 times greater (2.2 to 62.1, 95% CI) for the classic Norwood compared with the modified Norwood procedure. This difference was statistically significant by the Mantel-Haenszel chi2 (11.0, p = 0.001). The Breslow-Day statistic supported homogeneity of the odds ratios across hospitals (chi2 = 3.1, df = 4, p = 0.53).
The modified Norwood procedure has a significantly lower interstage mortality compared with the classic Norwood procedure. A large randomized study is needed to determine whether these results remain consistent.
据报道,与经典诺伍德手术相比,诺伍德手术的改良术式可降低术后即刻死亡率。改良诺伍德手术并未显示可降低二期手术死亡率,这可能是因为各机构的患者数量较少。本研究的目的是确定荟萃分析是否能提供足够的数据来证明改良诺伍德手术在二期手术死亡率方面存在统计学差异。
分别使用六个不同的检索词在PubMed上检索2003年1月至2004年10月的文章。对比较经典诺伍德手术与改良诺伍德手术的手稿进行综述。采用曼特尔-亨塞尔分析来评估治疗方法与各医院分层死亡率之间的关系。采用布雷斯洛-戴检验来检验各医院间比值比的同质性。分别对住院期和二期手术期进行分析。
共筛选出4545条引文。五篇手稿符合标准。72例行经典诺伍德手术的患者和84例行改良诺伍德手术的患者存活至首次出院。布雷斯洛-戴统计量支持各医院间生存比值比的同质性(χ2 = 2.09,自由度 = 4,p = 0.72)。与改良诺伍德手术相比,经典诺伍德手术二期死亡的几率高11.6倍(2.2至62.1,95%可信区间)。通过曼特尔-亨塞尔χ2检验,这种差异具有统计学意义(χ2 = 11.0,p = 0.001)。布雷斯洛-戴统计量支持各医院间比值比的同质性(χ2 = 3.1,自由度 = 4,p = 0.53)。
与经典诺伍德手术相比,改良诺伍德手术的二期死亡率显著降低。需要进行一项大型随机研究来确定这些结果是否仍然一致。